Blood cancer is a complex group of diseases that comprise those that adversely affect the production and function of blood cells. These include various types of leukaemia, lymphoma and myeloma, which all have different kinds of challenges. In contrast to solid tumours, blood cancer occurs in the bone marrow, blood cells or lymphatic system. Luckily, the advances in treatment have changed the game and the outcomes have improved significantly.
Here is a quick glance at the top five treatment strategies you should be aware of – their mechanisms, the time of use, benefits & drawbacks, and questions that patients should ask.
Top Five Treatment Approaches For Blood Cancer
These are the most recent and advanced treatment options for blood cancer. Every person should know.
1. Chemotherapy
Chemotherapy remains one of the major methods of treatment for different kinds of blood cancer. Typically, chemotherapy is very toxic to cells that divide rapidly (it can be done by infusion, injection, or orally) and since cancer cells are those that divide rapidly, they are the main target of the therapy. In the case of blood cancers, particularly those accompanied by the proliferation of abnormal blood cells, chemotherapy can be effective in decreasing or eradicating such cells.
When It is Used
- Usually, very aggressive chemotherapy serves as the first line of treatment in the case of acute leukemias (for instance, acute myeloid leukemia or acute lymphoblastic leukemia).
- In lymphomas, it is also a work of the doctor’s choice which can be utilized only or combined with other treatments (e.g., rituximab + chemo in non-Hodgkin lymphoma).
- As a component of conditioning regimens prior to a stem-cell transplant.
Pros:
- Chemotherapy is accessible to the public in most parts of the world and has been tested through many clinical trials over decades.
- It is capable of bringing about remission in numerous cases, especially if employed at the initial stages of the disease.
Cons:
- On the downside, chemo is not selective: healthy cells that also divide rapidly (e.g., hair follicles, gut lining, bone marrow) are likewise harmed – thus, the patient experiences side effects such as hair loss, nausea, and low blood counts.
- Some blood cancers develop resistance to chemo, thus implying the need for other therapies.
- Also, the rigor of chemo protocols can wear down the patient’s physical condition, particularly if the patient is elderly or has other diseases besides cancer.
2. Targeted Therapy
The targeted therapy is also more accurate compared to the traditional chemotherapy: it goes after specific molecular abnormalities or cancer cell signalling pathways, thus healthy cells are affected less (to some extent). These are drugs that locate and eventually interfere with certain targets within the cancer cell, those could be mutated genes or overexpressed proteins. For instance, in chronic myeloid leukemia (CML), the adoption of a tyrosine-kinase inhibitor (TKI) has changed the outcome drastically.
When It Is Used
- In subtypes of blood cancers, a driver mutation or abnormal target is identified. An example would be CML which has the BCR-ABL mutation and is treated with imatinib.
- Targeted therapy is also usually combined with other treatments if the patient’s condition is not responsive to the standard regimen.
- Moreover, the therapy is administered as maintenance treatment in few cases with the aim of preventing relapse or disease progression.
Pros:
- Highly selective – generally have less side effects than a full blown aggressive chemo regimen.
- In some cases, what once was a fatal diagnosis can be turned into a chronic, manageable condition.
Cons:
- It can only be effective if the cancer carries the target – not all blood cancers have a known or druggable target.
- Over time, resistance to the drug might arise, thus requiring new agents or combinations.
- These medicines can be costly, and long-term follow-up is necessary.
3. Immunotherapy (Including CAR-T & Monoclonal Antibodies)
Immunotherapy is a therapeutic method which either uses the body’s immune system as it is or upgrades it to combat cancer. The two major breakthroughs which gradually lead to the elimination of blood cancers are immunoglobulins and chimeric antigen receptor (CAR) T-cell therapy. The methods are:
- Monoclonal antibodies: artificially formed immune proteins that go and bind with the newly strict markers on the surface of the cancer cells, thus either killing those cells directly or getting them ready for destruction by other cells.
- CAR-T cell therapy: The patient’s T-cells are removed, in a lab genetically changed to recognize the cancer that will be targeted cells, and then put back to the patient. Thus, the changed T-cells are able to find the cancer cells and destroy them.
When it is used
- Immunotherapy is a rescue treatment for patients with relapsed or refractory blood cancers (i.e., those which have not responded to standard therapy).
- With time and research findings, some are now gradually advancing to the forefront of therapy.
- It is when a particular marker (e.g., CD19 in B-cell malignancies) that the therapy is used.
Pros:
- Has the potential to provide a remission that may last for years, even after therapy has been discontinued–in a tiny fraction of a patient population, a complete remission with no trace of the disease has been observed.
- By opening up a brand-new arena of cancer treatment, this is a source of hope for those who have a very limited number of options left.
Cons:
- The main side effects are extremely unpleasant: cytokine release syndrome and neurotoxicity in CAR-T therapies.
- Individually, the main issues about the product are poor affordability and the significant effort that must be maintained in the production and monitoring of the drug (special centres, monitoring).
- There are some contraindications that make patients ineligible: The expression of the target antigen, and the physical condition of the patient which must be good enough to tolerate the therapy.
- The matter of side effects and changes observed in patients over an extended period is what is left to be investigated.
4. Stem Cell Transplantation (Bone Marrow / Haematopoietic Stem Cell Transplant)
This is a major source of therapy, mostly for those suffering from high-risk or relapsed blood cancers. The process includes the replacement of the patient’s malfunctioning blood-forming system with healthy donor stem cells. How it works:
- To annihilate the cancer cells and the diseased bone marrow, the patient has to be subjected to a round of severe chemotherapy and/or radiation.
- The restored cells (haematopoietic stem cells) can be either the patient’s own cells that were collected and preserved beforehand (autologous) or a donor’s cells (allogeneic).
- The immune cells of the donor in an allogeneic transplant may identify the patient’s cancer cells as foreign and hence kill them (graft-versus-leukaemia effect).
When it is used
- In acute leukaemias with a significant risk of relapse (e.g., poor-risk cytogenetics).
- Where the disease has relapsed, and there is no response to other therapies.
- As consolidation in certain lymphomas and myelomas condition.
Pros:
- If the patient is fortunate enough, and especially in the case of an allogeneic transplant, there is the potential for a cure.
- An immune system reset plasm can be drawing from the procedure.
Cons:
- It takes a toll on the body: the patient is vulnerable to infections, and the development of graft-versus-host disease is possible (in donor transplant), as is treatment-related mortality.
- Not every patient is suitable for it- elderly people, those with health conditions, and those without donor matches are some of such people.
- Owing to the need for subsequent follow-ups, and also the therapy may impinge on one’s quality of life, this treatment is a major engagement.
5. Radiation Therapy & Supportive Care
These therapies include radiation directed at specific areas, the developing field of precision medicine, and supportive care, which is the treatment that is given to patients in addition to their regular therapy.
Radiation Therapy
However, unlike many solid tumours, the use of radiation is limited in blood cancers but still:
- Helps in the case of localised lymphomas (e.g., lymphoma masses in lymph nodes).
- It can be used for the relief of bone pain caused by lesions in myeloma.
- Together with the main therapy, stem cell transplant, it is given as a part of the conditioning regimen (total body irradiation).
Precision Medicine, Supportive Care & Emerging Modalities
- On-demand intervention: In fact, genetic testing along with molecular diagnosis are the major factors which lead treatment decision just by depicting the tumour individual’s features.
- Supportive care: The main treatment side effects which come along and are controlled by routines such as transfusions, growth factors (to stimulate blood counts), anti-infection measures, and nutrition, are of great value.
- Next generation therapies: The majority of novel therapy cases such as new immunotherapy agents, gene therapy, and antibody-drug conjugates resulting from clinical trials are still not being spread widely for the general population.
What You Should Know as a Patient or Caregiver
Here are some important tips for better outcomes:
- Learn the facts: Elevate your knowledge about the subtype of the blood cancer of you or your loved ones, what molecular tests were conducted, and how this data is utilized for therapy.
- Ask about the entire plan: Normally, the treatments are a combination of two or more from the five categories that have been mentioned above.
- Think of the centre and the expertise: For instance, some therapies (like CAR-T, transplant) require specialised centres that have more experience and resources to carry them out.
- Side effects and costs should also be considered: Some of the newest drugs are expensive or come with complex monitoring requirements; supportive care remains very vital.
- Hold on to hope, but be realistic as well: By and large, blood cancers may be the major diseases of the past and are treatable – even curable in some cases. However, success is often reliant on factors such as early diagnosis, good health, and access to the right care.
- Always keep up-to-date with new treatment options: There is always a new clinical trial to open a new door – so, if you don’t respond to standard therapies, ask if you are eligible for a trial.
Conclusion
Whether you are a newly diagnosed blood cancer patient or supporting someone through treatment, the knowledge of the five main treatment categories – chemotherapy, targeted therapy, immunotherapy, stem-cell transplant, and radiation/supportive care/precision approaches – provides you with a framework to understand the options, ask intelligent questions, and participate in the care process. Treatment decisions are intricate and very personal, yet producing the desired effect differently, they will empower you if you are well informed.
Abdullah